Doppel protein (Dpl), encoded by the PRND gene, is structurally and functionally related to the prion protein (PrP), albeit with distinct physiological roles primarily outside the central nervous system. Unlike PrP, Dpl is primarily expressed in the testis, suggesting a specialized role in spermatogenesis or testicular function. Emerging evidence also points to Dpl's involvement in cell signaling pathways, potentially influencing cell proliferation, differentiation, and survival. The protein's role in neurobiology, while less pronounced than PrP, indicates a broader functional repertoire, possibly impacting neural cell development and maintenance. Dpl's activation and its subsequent cellular effects are thought to be mediated through its interaction with specific cell surface receptors or intracellular signaling molecules, initiating cascades that regulate cellular processes essential for normal development and physiological functioning.
The activation mechanisms of Dpl are intricately linked to its expression levels, post-translational modifications, and interactions with other proteins. Regulation at the transcriptional level determines Dpl availability, with specific factors enhancing its gene expression in response to physiological demands, particularly within the reproductive system. Post-translational modifications such as phosphorylation could further modulate Dpl's activity by altering its conformational state, promoting or inhibiting its interaction with binding partners, and affecting its cellular localization. The engagement of Dpl with membrane-bound receptors or components of intracellular signaling pathways can activate downstream effects, including alterations in gene expression, modulation of apoptotic pathways, or changes in cell cycle progression. This activation is critical for Dpl to exert its effects on cell function and highlights the complex regulatory environment governing its activity. Understanding the pathways and mechanisms underlying Dpl activation offers insights into its physiological roles and the potential for its dysregulation to contribute to disease states, emphasizing the importance of delineating these processes for a comprehensive understanding of Dpl's function in health and disease.
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Quinacrine, Dihydrochloride | 69-05-6 | sc-204222 sc-204222B sc-204222A sc-204222C sc-204222D | 100 mg 1 g 5 g 200 g 300 g | $45.00 $56.00 $85.00 $3193.00 $4726.00 | 4 | |
Quinacrine is an anti-prion compound that inhibits prion protein aggregation, indirectly influencing Dpl. | ||||||
Suramin sodium | 129-46-4 | sc-507209 sc-507209F sc-507209A sc-507209B sc-507209C sc-507209D sc-507209E | 50 mg 100 mg 250 mg 1 g 10 g 25 g 50 g | $149.00 $210.00 $714.00 $2550.00 $10750.00 $21410.00 $40290.00 | 5 | |
Suramin is a compound that can inhibit prion replication, indirectly impacting Dpl by interfering with prion propagation. | ||||||
Amphotericin B | 1397-89-3 | sc-202462 sc-202462A sc-202462B | 100 mg 500 mg 1 g | $69.00 $139.00 $219.00 | 10 | |
Amphotericin B reduces prion infectivity, indirectly influencing Dpl by targeting prion-related processes. | ||||||
Congo Red | 573-58-0 | sc-359843 sc-359843A sc-359843B sc-359843C | 25 g 100 g 250 g 1 kg | $36.00 $87.00 $178.00 $495.00 | 4 | |
Congo Red inhibits prion protein aggregation, indirectly affecting Dpl by interfering with the formation of prion aggregates. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
EGCG, found in green tea, modulates prion-related processes by disrupting prion protein misfolding and aggregation. | ||||||
Polymyxin B Sulfate | 1405-20-5 | sc-3544 | 500 mg | $62.00 | 8 | |
Polymyxin B, an antibiotic, reduces prion infectivity, indirectly impacting Dpl by interfering with prion-related processes. | ||||||
Indomethacin | 53-86-1 | sc-200503 sc-200503A | 1 g 5 g | $28.00 $37.00 | 18 | |
Indomethacin, a non-steroidal anti-inflammatory drug, shows anti-prion activity by targeting prion protein misfolding. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $62.00 $108.00 $210.00 | 1 | |
Ribavirin, an antiviral compound, inhibits prion replication, indirectly affecting Dpl by interfering with prion-related processes. | ||||||
Heparin | 9005-49-6 | sc-507344 | 25 mg | $117.00 | 1 | |
Certain sulfated glycosaminoglycans, such as Heparin Sulfate, disrupt prion protein aggregation and modulate Dpl indirectly. |